Initial chemotherapeutic doses and long-term survival in limited small-cell lung cancer [4]

New England Journal of Medicine

Volumn 345, Issue 17, 2001, Pages 1281-1282

  Arriagada, Rodrigo ^a   Pignon, Jean Pierre ^a   Le Chevalier, Thierry ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE;

CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; HUMAN; LETTER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; SURVIVAL TIME;

EID: 0035950687     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200110253451715     Document Type: Letter

References (2)

1. Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer
2. Triangular test and randomized trials: Practical problems in a small cell lung cancer trial